Genetic variation in in-vitro cytokine-induced production of nitric oxide by murine peritoneal macrophages

被引:11
作者
Zídek, Z
Franková, D
Boubelík, M
机构
[1] Acad Sci Czech Republic, Inst Pharmacol, Prague 14220 4, Czech Republic
[2] Acad Sci Czech Republic, Inst Mol Genet, Prague 14220 4, Czech Republic
来源
PHARMACOGENETICS | 2000年 / 10卷 / 06期
关键词
nitric oxide; interferon-gamma; interferon-gamma receptor; tumour necrosis factor-alpha; interleukin-10;
D O I
10.1097/00008571-200008000-00002
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Quantitative aspects of the in-vitro interferon (IFN)-gamma-induced nitric oxide (NO) production by peritoneal macrophages of eight inbred strains of mice were investigated. Animals employed in the study can be assorted into three phenotype categories: high, moderate, and low NO-responders. Concentration of nitrites in the 24-h supernatants of cells stimulated with recombinant murine IFN-gamma (25 U/ml) reached the following values (mean a SERI; in mu M): C57BL/10 (33.7 +/- 1.88) = C57BL/6 (32.1 +/- 2.10) > SJL (24.0 +/- 1.55) > CBA/J (18.1 +/- 7.79) = C3H/HeN (18.0 +/- 1.10) > DBA/2 (11.4 +/- 1.16) = DBA/1 (11.0 +/- 1.20) = Balb/c (11.0 +/- 1.16). Approximately 80% of the total variation was found to be controlled by genetic factors. No association between the extent of NO formation and variation in the constitutive expression of macrophage IFN-gamma receptor was observed. Similar magnitude of inter-strain differences was sustained after enhanced RIG-stimulation of the cells with IFN-gamma + tumour necrosis factor (TNF)-alpha, but only high (strains BL/10, BL/6, SJL, CBA/J, C3H/HeN) and low (DBA/1, DBA/2, Balb/c) NO-responder phenotypes were detected after the triple cytokine cocktail composed of IFN-gamma + TNF-alpha + interleukin (IL)-10. The strain differences remained unchanged after the supplementation of culture medium with L-arginine or tetrahydrobipopterin. Genetically governed differences in IFN-gamma-induced NO production have been found to be tightly associated with differential expression of inducible nitric oxide synthase mRNA. Possible implications of the findings for various fields of NO biomedical research are discussed, Pharmacogenetics 10:493-501 (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:493 / 501
页数:9
相关论文
共 54 条
[1]  
ADLER H, 1995, J IMMUNOL, V154, P4710
[2]   LIGAND-INDUCED AUTOREGULATION OF IFN-GAMMA RECEPTOR-BETA CHAIN EXPRESSION IN T-HELPER CELL SUBSETS [J].
BACH, EA ;
SZABO, SJ ;
DIGHE, AS ;
ASHKENAZI, A ;
AGUET, M ;
MURPHY, KM ;
SCHREIBER, RD .
SCIENCE, 1995, 270 (5239) :1215-1218
[3]   The IFN gamma receptor: A paradigm for cytokine receptor signaling [J].
Bach, EA ;
Aguet, M ;
Schreiber, RD .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :563-&
[4]   SELECTIVE TARGETING OF NITRIC-OXIDE SYNTHASE INHIBITORS TO SYSTEM Y(+) IN ACTIVATED MACROPHAGES [J].
BAYDOUN, AR ;
MANN, GE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 200 (02) :726-731
[5]   Cellular responses to interferon-gamma [J].
Boehm, U ;
Klamp, T ;
Groot, M ;
Howard, JC .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :749-795
[6]  
BOGDAN C, 1994, INFEC DIS T, V15, P37
[7]   REGULATION OF NITRIC-OXIDE SYNTHASE ACTIVITY IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-INFECTED MONOCYTES - IMPLICATIONS FOR HIV-ASSOCIATED NEUROLOGICAL DISEASE [J].
BUKRINSKY, MI ;
NOTTET, HSLM ;
SCHMIDTMAYEROVA, H ;
DUBROVSKY, L ;
FLANAGAN, CR ;
MULLINS, ME ;
LIPTON, SA ;
GENDELMAN, HE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) :735-745
[8]  
CHESEBRO B, 1990, ANNU REV IMMUNOL, V8, P477, DOI 10.1146/annurev.iy.08.040190.002401
[9]   Role of nitric oxide in cell-mediated tumor cytotoxicity [J].
Cifone, MG ;
Cironi, L ;
Meccia, MA ;
Roncaioli, P ;
Festuccia, C ;
DeNuntiis, G ;
DAlo, S ;
Santoni, A .
ADVANCES IN NEUROIMMUNOLOGY, 1995, 5 (04) :443-461
[10]  
CLANCY RM, 1995, P SOC EXP BIOL MED, V210, P93